Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Emergent BioSolutions Begins Phase 3 Study Of Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP


RTTNews | Oct 15, 2021 06:46AM EDT

06:45 Friday, October 15, 2021 (RTTNews) - Emergent BioSolutions Begins Phase 3 Study Of Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC